Glenmark Pharmaceuticals Limited has appointed Arvind Vasudeva as chief operating officer. Vasudeva will be based at the Corporate headquarters in Mumbai and will report to the CEO & MD, Glenn Saldanha.

Vasudeva will be responsible for the entire Branded Generics business of Glenmark Pharmaceuticals i.e. divided into six regions - India, Asia-Pacific, Latin America, Russia/CIS, Africa/Middle East, and Central Eastern Europe. Glenmark branded generics business has offices in over 20 countries.

Vasudeva is a post graduate in pharmacy and has over 27 years of experience in the pharmaceutical industry. He has worked with leading pharmaceutical organizations like Astra-IDL, Dr Reddy's and Wockhardt. Prior to joining Glenmark, his last assignment was with RPG Life Sciences as managing director

Commenting on his appointment, Glenn Saldanha, CEO & MD, Glenmark Pharmaceuticals stated, "We are glad to have Arvind on board. He will be a tremendous asset to our team. Glenmark has grown rapidly in the recent years. Arvind has the experience and commitment to take the growth trajectory to the next level while ensuring that we remain committed to the values and vision of our organization."